These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24690253)

  • 41. White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.
    Kuroda T; Honma M; Mori Y; Futamura A; Sugimoto A; Kasai H; Yano S; Hieda S; Kasuga K; Ikeuchi T; Ono K
    J Alzheimers Dis; 2022; 85(2):851-862. PubMed ID: 34864676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus.
    Grønning R; Jeppsson A; Hellström P; Laurell K; Farahmand D; Zetterberg H; Blennow K; Wikkelsø C; Tullberg M
    Fluids Barriers CNS; 2023 Oct; 20(1):77. PubMed ID: 37880775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers.
    Jeppsson A; Zetterberg H; Blennow K; Wikkelsø C
    Neurology; 2013 Apr; 80(15):1385-92. PubMed ID: 23486875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
    Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
    J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebrospinal Fluid Levels of β-Amyloid 40 and β-Amyloid 42 are Proportionately Decreased in Amyloid Positron-Emission Tomography Negative Idiopathic Normal-Pressure Hydrocephalus Patients.
    Kim HJ; Lim TS; Lee SM; Kim TS; Kim Y; An YS; Youn YC; Park SA; Chang J; Moon SY
    J Clin Neurol; 2019 Jul; 15(3):353-359. PubMed ID: 31286708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus.
    Nakajima M; Miyajima M; Ogino I; Akiba C; Sugano H; Hara T; Fusegi K; Karagiozov K; Arai H
    J Neurol Sci; 2015 Oct; 357(1-2):88-95. PubMed ID: 26169158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P-Tau as prognostic marker in long term follow up for patients with shunted iNPH.
    Migliorati K; Panciani PP; Pertichetti M; Borroni B; Archetti S; Rozzini L; Padovani A; Terzi L; Bruscella S; Fontanella MM
    Neurol Res; 2021 Jan; 43(1):78-85. PubMed ID: 33059546
    [No Abstract]   [Full Text] [Related]  

  • 48. In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome.
    Giannini G; Baiardi S; Dellavalle S; Zenesini C; Cevoli S; Danner N; Jyrkkänen HK; Rossi M; Polischi B; Quadalti C; Stefanini C; Cortelli P; Milletti D; Herukka SK; Palandri G; Leinonen V; Parchi P
    Fluids Barriers CNS; 2022 Sep; 19(1):71. PubMed ID: 36071460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus.
    Mazzeo S; Emiliani F; Bagnoli S; Padiglioni S; Del Re LM; Giacomucci G; Balestrini J; Ingannato A; Moschini V; Morinelli C; Galdo G; Polito C; Ferrari C; Pansini G; Della Puppa A; Sorbi S; Nacmias B; Bessi V
    J Pers Med; 2022 Jun; 12(6):. PubMed ID: 35743720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peripheral immunity changes are associated with neurodegeneration and worse clinical outcome in idiopathic normal pressure hydrocephalus.
    Bissacco J; Simonetta C; Mascioli D; Zenuni H; Bovenzi R; Grillo P; Di Giuliano F; Stefani A; Mercuri NB; Schirinzi T
    Eur J Neurol; 2024 Mar; 31(3):e16179. PubMed ID: 38130035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential proteomic profile of lumbar and ventricular cerebrospinal fluid.
    Rostgaard N; Olsen MH; Ottenheijm M; Drici L; Simonsen AH; Plomgaard P; Gredal H; Poulsen HH; Zetterberg H; Blennow K; Hasselbalch SG; MacAulay N; Juhler M
    Fluids Barriers CNS; 2023 Jan; 20(1):6. PubMed ID: 36670437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.
    Alves G; Brønnick K; Aarsland D; Blennow K; Zetterberg H; Ballard C; Kurz MW; Andreasson U; Tysnes OB; Larsen JP; Mulugeta E
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1080-6. PubMed ID: 20547614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus.
    Graff-Radford NR
    Neurology; 2014 Oct; 83(17):1573-5. PubMed ID: 25332445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution of amyloid burden differs between idiopathic normal pressure hydrocephalus and Alzheimer's disease.
    Kondo M; Tokuda T; Itsukage M; Kuriyama N; Matsushima S; Yamada K; Nakanishi H; Ishikawa M; Nakagawa M
    Neuroradiol J; 2013 Feb; 26(1):41-6. PubMed ID: 23859166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.
    Agren-Wilsson A; Lekman A; Sjöberg W; Rosengren L; Blennow K; Bergenheim AT; Malm J
    Acta Neurol Scand; 2007 Nov; 116(5):333-9. PubMed ID: 17922727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The applause sign in elderly patients with idiopathic normal pressure hydrocephalus.
    Kaya D; Erken N; Ontan MS; Altun ZS; Isik AT
    Appl Neuropsychol Adult; 2022; 29(5):893-898. PubMed ID: 32907386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus.
    Brandner S; Thaler C; Lelental N; Buchfelder M; Kleindienst A; Maler JM; Kornhuber J; Lewczuk P
    J Alzheimers Dis; 2014; 41(4):1057-62. PubMed ID: 24748118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.
    Reijs BLR; Ramakers IHGB; Köhler S; Teunissen CE; Koel-Simmelink M; Nathan PJ; Tsolaki M; Wahlund LO; Waldemar G; Hausner L; Vandenberghe R; Johannsen P; Blackwell A; Vanderstichele H; Verhey F; Visser PJ
    J Alzheimers Dis; 2017; 60(3):1119-1128. PubMed ID: 28984585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperdynamic CSF motion profiles found in idiopathic normal pressure hydrocephalus and Alzheimer's disease assessed by fluid mechanics derived from magnetic resonance images.
    Takizawa K; Matsumae M; Hayashi N; Hirayama A; Yatsushiro S; Kuroda K
    Fluids Barriers CNS; 2017 Oct; 14(1):29. PubMed ID: 29047355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.